TY - JOUR
T1 - Open science, COVID-19, and the news
T2 - Exploring controversies in the circulation of early SARS-CoV-2 genomic epidemiology research
AU - Molldrem, Stephen
AU - Hussain, Mustafa I.
AU - Smith, Anthony K.J.
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Some early English language news coverage of COVID-19 epidemiology focused on studies that examined how SARS-CoV-2 (the coronavirus that causes COVID-19) was evolving at the genetic level. The use of phylogenetic methods to analyse pathogen genetic sequence data to understand disease dynamics is called ‘molecular’ or ‘genomic’ epidemiology. Many research groups in this subfield utilise open science practices, which can involve the circulation of early unreviewed findings on publicly-accessible venues online. From March to May 2020, media outlets covered early SARS-CoV-2 genomic studies that claimed to have discovered types of SARS-CoV-2 that had mutated to be more transmissible. We use methods from Science and Technology Studies (STS) to examine three cumulative cases in which unripe facts about SARS-CoV-2 genomics moved out of scientific publics and into mainstream news. The three cases are: (1) ‘A More “Aggressive” Strain of SARS-CoV-2?’, (2) ‘Eight SARS-CoV-2 Strains?’, and (3) ‘A “More Contagious,” “Mutant” Strain?’ In each case, findings were called into question and reporters’ framing was overly sensational. We interpret the COVID-19 pandemic as a ‘stress-test’ for open science practices, and argue that it is important for stakeholders to understand changes in scientific publication and dissemination processes in the wake of the pandemic.
AB - Some early English language news coverage of COVID-19 epidemiology focused on studies that examined how SARS-CoV-2 (the coronavirus that causes COVID-19) was evolving at the genetic level. The use of phylogenetic methods to analyse pathogen genetic sequence data to understand disease dynamics is called ‘molecular’ or ‘genomic’ epidemiology. Many research groups in this subfield utilise open science practices, which can involve the circulation of early unreviewed findings on publicly-accessible venues online. From March to May 2020, media outlets covered early SARS-CoV-2 genomic studies that claimed to have discovered types of SARS-CoV-2 that had mutated to be more transmissible. We use methods from Science and Technology Studies (STS) to examine three cumulative cases in which unripe facts about SARS-CoV-2 genomics moved out of scientific publics and into mainstream news. The three cases are: (1) ‘A More “Aggressive” Strain of SARS-CoV-2?’, (2) ‘Eight SARS-CoV-2 Strains?’, and (3) ‘A “More Contagious,” “Mutant” Strain?’ In each case, findings were called into question and reporters’ framing was overly sensational. We interpret the COVID-19 pandemic as a ‘stress-test’ for open science practices, and argue that it is important for stakeholders to understand changes in scientific publication and dissemination processes in the wake of the pandemic.
KW - Molecular epidemiology
KW - media studies
KW - pathogen genomics
KW - science and technology studies
KW - science communication
UR - http://www.scopus.com/inward/record.url?scp=85111908295&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111908295&partnerID=8YFLogxK
U2 - 10.1080/17441692.2021.1896766
DO - 10.1080/17441692.2021.1896766
M3 - Article
C2 - 33661076
AN - SCOPUS:85111908295
SN - 1744-1692
VL - 16
SP - 1468
EP - 1481
JO - Global Public Health
JF - Global Public Health
IS - 8-9
ER -